Depression and Anxiety Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 65 years of age
- People whose main diagnosis is generalised Social Anxiety Disorder, confirmed through a clinical evaluation, a structured psychiatric interview (called the MINI), and a score above 50 on a standard anxiety rating scale (called the LSAS)
- People with normal vision, or vision that is fully corrected with glasses or contact lenses, and who do not have colour blindness
- People with a sufficient level of Hebrew language ability to complete interviews, questionnaires, and computer-based tasks
Who may not be able to join:
- People who have previously taken part in a type of attention training called dot-probe attention bias modification
- People who have previously taken part in attention training that uses eye-tracking technology
- People who currently have a diagnosis of Post-Traumatic Stress Disorder (PTSD)
- People who currently have, or have previously been diagnosed with, a psychotic disorder or bipolar disorder
- People who have a neurological condition, such as epilepsy or a brain injury
- People who are experiencing severe thoughts of suicide
- People who currently have a substance use or alcohol use disorder
- People who are currently receiving medication or psychological treatment, unless their medication dose has been stable for at least 45 days (confirm with trial site)
- People who are pregnant
- People who have uncorrected vision problems, or who wear multifocal glasses
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yair Bar-Haim, PhD, Tel Aviv University
Phone: 97236405465
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in social anxiety symptoms
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.